Syngene AGM 2026: Date, dividend, board changes details

Key announcement and why it matters

Syngene International has scheduled its 33rd Annual General Meeting (AGM) for Wednesday, July 29, 2026. The meeting will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM), as indicated in the company’s disclosures and newspaper advertisement. For shareholders, the AGM is the formal forum where items such as dividend approval and board and auditor-related decisions are put to vote. This year’s notice also carries clear process details on how shareholders can access documents and participate remotely. Alongside the AGM schedule, Syngene’s board has outlined director appointments and a statutory auditor proposal that require shareholder approval.

33rd AGM schedule, time, and mode

The company has said the 33rd AGM will be held at 3:30 pm IST on July 29, 2026. It will be hosted only through VC/OAVM, and shareholders will need to attend and participate through the remote facility rather than a physical meeting format. The newspaper advertisement notes that the AGM will transact the business set out in the 33rd AGM notice. Syngene has also indicated that the “deemed venue” concept continues to apply for VC AGMs, based on the company’s prior AGM communication format.

Final dividend proposal for FY ended March 31, 2026

Syngene’s Board of Directors, at its meeting held on April 29, 2026, recommended a final dividend of Rs 1.25 per equity share. The disclosure specifies that the equity shares have a face value of Rs 10 each. The dividend is for the financial year ended March 31, 2026 and will be placed before shareholders at the 33rd AGM for approval. The company has fixed Friday, June 26, 2026 as the record date for the purpose of the final dividend for FY 2025-26. It has also stated that the final dividend, once approved, will be paid on or before 30 days from the date of the AGM, through electronic transfer modes to eligible shareholders who have updated the required details.

Board appointments: independent directors and reappointment

Syngene’s board has approved the appointment of two additional independent non-executive directors, subject to shareholder approval at the upcoming AGM. Mr. Vijaya Chandru has been appointed as an Additional Independent Non-Executive Director for a period of three years from the conclusion of the 33rd AGM in July 2026. Mr. Arun Chandavarkar has also been appointed as an Additional Independent Non-Executive Director for a period of three years from the conclusion of the 33rd AGM in July 2026.

The company has also stated a reappointment for Ms. Vinita Bali as an Additional Non-Executive Director for one year from July 22, 2026 to July 21, 2027. The board approvals were based on recommendations of the Nomination and Remuneration Committee. Syngene also confirmed that none of the appointees are debarred from holding director positions by SEBI or any authority, as per the provided notes.

Statutory auditor proposal linked to the 33rd AGM

In the same April 29, 2026 board meeting disclosure, Syngene said it approved, based on the Audit Committee’s recommendation and subject to shareholder approval, the appointment of M/s S. R. Batliboi & Associates LLP as statutory auditors. The proposed tenure is five years commencing from the conclusion of the 33rd AGM until the AGM to be held in the year 2031. This agenda item, like director appointments, requires shareholder consent at the AGM.

How notices and annual report will be shared

Syngene has stated that the Notice of the 33rd AGM along with the Annual Report for FY 2025-26 will be sent only by electronic mode to shareholders whose email IDs are registered with the company or depository participants. The same documents will also be made available on the company’s website (www.syngeneintl.com). In addition, the disclosures specify availability on the websites of BSE Limited and the National Stock Exchange of India Limited, and on the Registrar and Share Transfer Agent portal of KFin Technologies Limited (https://evoting.kfintech.com/public/Downloads.aspx). This structure mirrors the company’s recent practice of conducting shareholder meetings and communications digitally.

Share price context provided

The data provided with the announcement notes that the share price of SYNGENE as on June 24, 2026 was Rs 437.05. This is a reference point investors may track around corporate action dates such as record dates and AGMs. The disclosures shared focus on the meeting schedule, dividend record date, and governance proposals rather than any trading update.

What Syngene’s prior AGM disclosures show (32nd AGM)

Syngene’s earlier communication for the 32nd AGM shows the company has been using VC/OAVM formats and e-voting processes. The 32nd AGM was scheduled on Wednesday, July 23, 2025 at 3:30 pm IST through VC/OAVM. The proceedings excerpt also described that notices and the annual report for FY 2024-25 were sent through email in compliance with MCA and SEBI circulars.

The 32nd AGM agenda referenced multiple ordinary resolutions and one special resolution. It included adoption of audited standalone and consolidated financial statements for the year ended March 31, 2025, and a dividend of Rs 1.25 per equity share for that financial year. The proceedings also described a remote e-voting window from July 18, 2025 (9:00 am) to July 22, 2025 (5:00 pm), and an “Insta poll” facility through the company’s RTA, KFin Technologies Limited, for those attending the meeting and voting during the AGM.

Summary table: key dates and items

Governance items to be voted on at the 33rd AGM

Based on the information provided, shareholder voting at the 33rd AGM will be relevant for three key governance decisions. First is the approval of the final dividend of Rs 1.25 per equity share for FY ended March 31, 2026. Second is approval for the appointment of Mr. Vijaya Chandru and Mr. Arun Chandavarkar as additional independent non-executive directors for three years from the conclusion of the 33rd AGM, along with the reappointment of Ms. Vinita Bali for the stated one-year period. Third is the proposed appointment of S. R. Batliboi & Associates LLP as statutory auditors for five years from the conclusion of the 33rd AGM through the AGM to be held in 2031.

Closing note

Syngene’s disclosures set out a clear timeline into late July 2026, with the AGM as the key approval point for the dividend, board appointments, and statutory auditor proposal. The record date for the final dividend is June 26, 2026, and the meeting itself is scheduled for July 29, 2026 at 3:30 pm IST via VC/OAVM. Shareholders will need to rely on electronic communications and the company and exchange websites to access the AGM notice and annual report for FY 2025-26. The next formal update in this sequence will be the AGM notice and the shareholder voting outcomes after the meeting concludes.